Fortress Biotech, Inc.
FBIOP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
In the last 90 days, Fortress Biotech, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.
Other share classesFBIO
13F holders, Q3 2026
Institutional positions in Fortress Biotech, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- 0 vs. Q2 2026
- Shares held
- 0
- 0 vs. Q2 2026
- Total value
- $0
- $0 vs. Q2 2026
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Holders and value by quarter
Institutions reporting FBIOP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 0 | $0 |
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $262.0K |
| Q1 2023 | 1 | $966.0K |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $1.16M |
| Q2 2022 | 1 | $1.37M |
| Q1 2022 | 3 | $5.87M |
| Q4 2021 | 3 | $6.98M |
| Q3 2021 | 3 | $7.29M |
| Q2 2021 | 3 | $7.51M |
| Q1 2021 | 3 | $6.95M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Fortress Biotech, Inc.; share changes are against Q2 2026.
No institution reported holding FBIOP in Q3 2026.